| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9015 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y601-0101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate |
2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2020-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020532747-A |
| titleOfInvention |
Pancreatic cancer diagnostic method using methionyl tRNA synthase and pancreatic cancer diagnostic kit using this |
| abstract |
The present invention relates to a method for diagnosing pancreatic cancer using methionyl-tRNA synthetase (MRS). If MRS is used as a pancreatic cancer marker, the diagnostic accuracy is significantly higher than that of conventional pancreatic cancer markers such as CEA. By analyzing the expression of MRS (methionyl-tRNA synthetase) from pancreatic cells, pancreatic cancer can be treated. It has the effect of being able to clearly determine whether or not it is present, and these effects are extremely useful for diagnosing pancreatic cancer in that they also appear in cells determined to be atypical cells by general staining methods. can do. |
| priorityDate |
2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |